Particularities of Cancer Management in HIV+ patients. Clinical Case Kaposi’s Sarcoma-Visceral Form

Author(s) :

Ioana Florescu1

1Oncology Department, Coltea Clinic Hospital, Bucharest, Romania

Corresponding author: Ioana Florescu, Email:

Published: Volume III, Issue 1, 1 April 2023, 37 - 46 DOI: 10.53011/JMRO.2023.01.07

Open Access

Full text


April 1, 2023 0 Comments


Globally, 35 million people are infected with HIV, and this population has an increased risk of developing cancer.

We are reporting the case of a 44-year-old male patient who is HIV-positive. He is a smoker and an occasional drinker but is otherwise healthy. He was diagnosed with a visceral form of Kaposi sarcoma in January 2022 and has received 12 cycles of oncologic treatment with liposomal doxorubicin at our facility.

Fig.1 A and B Endoscopic view of the hemorrhagic lesions found at gastric level
Fig. 2 Oral cavity at presentation
Fig. 3 Trunk at presentation
Notify of
Inline Feedbacks
View all comments